Oct 2026· Journal of Clinical Medicine· Vol 15, pp. 8097· 0 citations· 14 references
Medicine
TL;DR
In this single-center, non-comparative series, robotic colorectal surgery was feasible during program implementation, with acceptable short-term perioperative outcomes, and comparisons are needed to determine its relative performance compared with laparoscopy.
Abstract
Background: Robotic-assisted colorectal surgery is increasingly adopted; however, evidence regarding outcomes during the early implementation phase remains limited. This study aimed to evaluate the feasibility and short-term outcomes of a newly established robotic colorectal surgery program at a tertiary referral center. Methods: All consecutive patients undergoing robotic colorectal resection between November 2019 and February 2026 were prospectively recorded and retrospectively analyzed. Perioperative outcomes, conversion rates, postoperative complications, in-hospital mortality, and histopathological results were assessed. Results: A total of 177 patients were included, with a progressive increase in surgical volume over time. Most procedures were performed for oncological indications (159, 90%), while 18 (10%) were performed for benign diseases. The most frequent procedures were right hemicolectomy (45%), left hemicolectomy (32%), and low anterior rectal resection (23%). Mean operative time was 331.1 ± 75.0 min. Conversion to open surgery occurred in 15 patients (8.5%), mainly due to extensive intra-abdominal adhesions, particularly during the early phase of the program. Postoperative complications occurred in 20 patients (11%), while 3 patients (2%) died during hospitalization. Major complications (Clavien–Dindo ≥ III) occurred in 7%, and anastomotic leakage in 3%. Mean hospital stay was 10.1 ± 7.6 days. R0 resection was reported in all cases, with adequate lymph-node retrieval for staging. Conclusions: In this single-center, non-comparative series, robotic colorectal surgery was feasible during program implementation, with acceptable short-term perioperative outcomes. Comparative studies are needed to determine its relative performance compared with laparoscopy.
Rehospitalization differed in direction between these cancers, indicating that cancer type and comparator selection materially affect inference, and these associations do not establish a platform-specific benefit or transferable bed-day savings.
Jaehyeong Cho, Hyo-Jung Kim, C. Cho· Journal of Clinical Medicine· 0 citations
INTRODUCTION
Robotic surgery offers potential advantages for the surgical management of rectal cancer; however, robust data on its use in locally advanced rectal cancer (LARC) populations are limited. We aimed to evaluate the long-term oncological and perioperative outcomes of robotic surgery in a cohort of patients tr...
Prateek Arora, Aseem Jindal, Lucy Larby et al.· Journal of Minimal Access Su...· 0 citations
Background/Aim: Patients with transverse colon cancer have been excluded from randomized controlled trials due to its anatomical complexity and high technical difficulty. Few studies have compared robotic surgery with laparoscopic or open surgery for transverse colon cancer. We conducted a comparative analysis of the s...
T. Shiraishi, T. Tominaga, Koki Wakata et al.· Anticancer Research· 0 citations
Objective: This study aimed to evaluate the safety and feasibility of robotic-assisted cholecystectomy using the CMR
Versius system and to characterize operative performance during the initial institutional experience.
Study design and setting: This retrospective cohort study took place at Surgical Unit 4, Ward 21, Jin...
Mansab Ali, Hamra Afridi, S. Dawani et al.· Journal of Bahria University...· 0 citations
Robotic surgery was associated with a 2.5-fold increased rate of a 'perfect' operation for colorectal cancer and reduced LOS after rectal resection, supporting the concept of cumulative marginal gains associated with robotic surgery.
M. P. Johansen, Victoria Rosberg, A. H. Nordholm et al.· Colorectal Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.